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Abstract
Iron oxide nanoparticles and in particular Fe3O4 Nanoparticles are new materials used in biotechnology and nanotechnology, Food
and drugs administration has approved several coated and bare Iron oxide nanoparticless and they are actually used in biomedical
applications as: Magnetic Resonance Imaging contrast agent, Thermotherapy agent, Drug carrier for cancer treatments, and so on.
All this applications bring risk of: a single exposure, workplace exposure, incidental and environmental release and potential long
life use. In this regard, iron oxide nanoparticles toxic effect, in particular neurotoxicity is not well known and it needs to be assessed.
The aim of this review is to present several iron oxide nanoparticles in vitro and in vivo studies that reflex Fe3O4 actual an overview
toxicological profile. Keywords: IONP, toxic effect, risk, nanotechnology.
Resumen
Nano partículas de óxido de hierro y en particular las nano partículas Fe3O4 son nuevosmateriales usados en biotecnología y nanotec-
nología, la Administración de Alimentos y Drogas ha aprobado varios nano partículas de óxido de hierro recubiertas y descubiertas
que se están utilizando para aplicaciones de biomedicina tales como: agentes de contraste en Imágenes de Resonancia Magnética,
agentes de Termoterapia, transportadores de fármacos para tratamientos de cáncer, entre otros. Todas estas aplicaciones implican
riesgo de tipo: única exposición, exposición en el espacio laboral, descargas accidentales y ambientales y potencial uso prolongado.
En este sentido, el efecto tóxico de las nano partículas de óxido de hierro, en particular de la toxicidad neuronal no son bien conocidas
y necesitan ser estudiadas. El propósito de esta revisión es presentar varios estudios de nano partículas de óxido de hierro in vitro e
in vivo que reflejan el perfil toxicológico de Fe3O4 . Palabras claves: IONP, efecto tóxico, riesgo, nanotecnología.
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1. Introducción
Nanotechnology is the science that deals with mat-
ter at the scale of 1 billionth of a meter (10 −9 m =
1 nm), and is also the study of manipulating matter
at the atomic and molecular levels. A nanoparticle
is the fundamental component in the fabrication of
a nanostructure, and is far smaller than the world
of everyday objects that are described by Newton’s
laws of motion, but bigger than an atom or a sim-
ple molecule that are illustrated by quantummecha-
nics’ laws (Horikoshi y Serpone, 2013).
Nanoparticles exhibit unconventional or enhan-
ced physico-chemical properties, which are not en-
countered in the corresponding bulk materials (e.g.,
lower melting points, higher specific surface areas,
specific optical properties, mechanical strengths,
and specific magnetizations). Their physical and
chemical properties depend not only on their com-
position, but also on the particle size, shape and ag-
gregation (Jiang et al., 2014).
Nowadays, nanoparticles have become trendset-
ter materials, every day we could find a new disco-
very or application development around nanoparti-
cles. Actually, there is a catalogue of commercial na-
noparticles for example: NanoGardTM LL Zinc oxi-
de, Zinc oxide NanoTekTM, NanoArkTM cerium oxi-
de, NanoArkTM Copper oxide, and so on. They are
used as biosensors or iron nanoparticles against can-
cer and more, these are simple examples of their
multifunctional uses. In general, biotechnology and
biomedicine are two of the most highlight fields to
apply nanoparticles technology.
2. Iron oxide nanoparticles (Mag-
netic nanoparticles)
Most materials found in Earth are generally thought
of as being nonmagnetic, for example, either dia-
magnetic (repelled weakly from a magnetic field, as
is water and almost any fatty substance) or para-
magnetic (weakly attracted to a magnetic field, as is
deoxyhemoglobin in blood cells). For these types of
materials, the direct physical influence of the earth’s
magnetic field is extraordinarily weak (Kirschvink
et al., 1992). However, nanomaterial’s magnetic pro-
perty is based on its magnetic susceptibility, which
is defined by the ratio of the induced magnetiza-
tion to the appliedmagnetic field. The susceptibly of
the material depends on their temperature, external
magnetic field and atomic structure (Indira y Laksh-
mi, 2010).
The rich history of scientific interest in Iron Oxi-
des Nanoparticles (IONPs) has been fuelled by va-
luable applications taking advantage of catalytic,
electronic, and magnetic properties of these mate-
rials. At present, IONPs are part of nanomaterial’s
science and engineering and they, in particular, are
developed based on their unique properties: colloi-
dal stability, hydrodynamic diameter (HDD) and ca-
pacity to response to magnetic fields (superpara-
magnetism) (Zhang et al., 2014). However, IONPs
are actually in process of development in order to
obtain new applications reducing their potential to-
xic effect.
IONPs are multifunctional, specifically for me-
dical, biotechnological and pharmaceutics applica-
tions development. The materials in nanostructu-
red form are the excellent candidates as probes be-
cause they can achieve high response to very small
targets in practical conditions. Nanomaterials (e.g.,
nanoparticles, nanowires, nanotubes, and even Na-
nodevices) have been explored in many biomedical
applications (e.g., biosensing, biological separation,
molecular imaging, and anticancer therapy) becau-
se their novel properties and functions differ drasti-
cally from the bulk counterparts (Chi et al., 2012).
At present, Fe3O4 iron oxide nanoparticles
(Fe3O4-NPs) are involved in biomedical and bio-
technological application, it is due to their good to-
lerance showed in vivo and the evident lower toxic
effect compared with Fe2O3 iron oxide nanoparti-
cles (Wang et al., 2011; Pisanic et al., 2007). In particu-
lar, the excellent properties of Fe3O4-NPs give rise to
numerous multitask applications including Magne-
tic Resonance Imaging (MRI) contrast agents, mul-
timodal imaging, ferrofluid technology for thermot-
herapy, targeted drug delivery, cancer tumor detec-
tion via magnetometry, gene therapy, biomolecular
separation, in vivo biomolecular detection, and tis-
sue repair (Deng et al., 2014; Wu et al., 2013; Singh
et al., 2010).
The surface engineered Fe3O4-NPs (e.g. with tar-
geting ligand/ molecules attached to their surfa-
ces) used together with the aid of an external mag-
netic field is recognized as a modern technology
to introduce particles to the desired site where the
drug is released locally represent a great advantage
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to Fe3O4-NPs per se. Engineered Fe3O4-NPs, such a
system, has the potential to minimize the side effects
and the required dosage of the drugs (Kim et al.,
2012). However, once the engineered Fe3O4-NPs are
inside the cells, the coating is likely digested leaving
bare particles exposed to cellular components and
organelles thereby potentially influencing the ove-
rall integrity of the cells. Fe3O4-NPs with appropria-
te surface chemistry exhibit many interesting pro-
perties that can be exploited in a variety of bio-
medical applications such as MRI contrast enhan-
cement, tissue repair, hyperthermia, drug delivery
and in cell separation (Mahdavi et al., 2013; Singh
et al., 2010).
3. Iron oxide nanoparticles toxi-
city
Nowadays, IONPs remain the only magnetic na-
noparticles that have been approved for clinical
use and commercially available approved by Food
and Drugs Administration (FDA) (Busquets et al.,
2014; Mahmoudi et al., 2009). However, accumula-
ting evidence indicates that exposure to IONPs cau-
ses apoptosis and alters the functionality of macrop-
hages. In fact, exposure of the murine macropha-
ge cell line J774 to IONPs resulted in an increased
production of intracellular Reactive Oxygen Species
(ROS), with subsequent cell injury and apoptosis
(Shen et al., 2011). Experimental studies have shown
that metal and metal oxide nanoparticles induced
DNA damage and apoptosis through ROS gene-
ration and oxidative stress (Ahamed et al., 2011).
Fe3O4-NPs, in particular, could produce; oxidative
stress following a direct route through Fe+2 and
Fe+3 ions liberation from nanoparticles themself
(Sun et al., 2013), by a surface catalytic action over
H2O2 (Lu et al., 2007) producing OH and OH− those
are highly reactive species (Luo et al., 2014); and pro-
ducing inflammation reactions (Ahamed et al., 2011;
Choi et al., 2009).
The direct route to produce ROS by Fenton,
Fenton-like and Heber-Weiss reactions is described
below. The following equation illustrated reaction
models and subsequent products (Luo et al., 2014;
Yan et al., 2013). Equations (1), (2) and (3) show the
reactions mediated by Fe+2
Fe(s) +H2O2 + 2H+ −→ Fe+2 + 2H2O (1)
Fe+2 +O2 −→ Fe
+3 + ·O2 (2)
Fe+2 + ·O−2 + 2H
+ −→ Fe+3 +H2O2 (3)
The presence of iron Fe+3 ions at the end of the
reactions chain produce new reactions involved in
ROS production described by Yah and co-workers
(2012). In this case, this reaction could reintroduce
iron Fe+2 ions to the reaction chain and increase the
ROS amounts. In the reaction (5) we could see, at
the end of the reaction, the presences of Fe+2 ions
that might enter in (2), (3) reaction, brining an vir-
tual endless circle of reactions.
Fe+3 +H2O2 −→ FeOOH+2 +H+ (4)
FeOOH+2 −→ Fe+2 + ·O2H (5)
Fe+2 +H2O2 −→ Fe+3 +OH− + ·OH (6)
Both, inflammation route and the surface cataly-
tic capacity are not described well at cellular level.
Over the toxicology point of view, Fe3O4-NPs are
good tolerated in vivo showing no toxic effect (Wu
et al., 2013; Wang et al., 2011; Weissleder et al., 1989).
In contrast, others in vivo studies show a fairy to-
xic effect over different tissue and cell, i.e. Shen and
co-workers (2011) have reported Fe3O4-NPs indu-
ced a differential effect on antigen-specific cytokine
expression by T cells. In addition, the suppressive
effect of Fe3O4-NPs on interferon-γ was closely as-
sociated with the diminishment of glutathione. Ho-
wever, further information about toxicity of Fe3O4-
NPs is missing.
4. Iron oxide nanoparticles neu-
rotoxicity
A better understanding of how properties of na-
noparticles define their interactions with cells, tis-
sues, organs and systems in animals and humans
is a scientific challenge, but one that must be ad-
dressed to ascertain the feasibility of using nano-
biotechnologies in biomedical applications (Cenge-
lli et al., 2006). In general, IONPs represent a risk
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because they may release iron ions, this might pro-
duce a disruption of normal iron metabolism in the
brain that is a characteristic of several neurodegene-
rative disorders such as: Alzheimer’s disease (AD),
Parkinson’s disease and progressive supranuclear
palsy (Bajaj et al., 2009). For example, excess iron ac-
cumulation is known to occur in AD patients, parti-
cularly in AD plaques and total iron levels are eleva-
ted in the hippocampus, amygdala and the cerebral
cortex (Hautot et al., 2003; Dobson, 2001). However,
functionalized Fe3O4-NPs are active investigated as
a T1 and T2 MRI agent, this characteristic are one
of the principal strategies for develop an early AD
diagnosis tool (Busquets et al., 2014). Based on, de-
tection or identification of amyloid plaques, using
IONPs as negative contrast agents.
Schafer and co-workers (2000) affirm that va-
rious experiments have also demonstrated that iron-
oxygen complexes may be even more effective ca-
talysts for free-radical damage in brain tissue than
the Fenton reaction, so the potential deleterious ef-
fect of magnetite is possibly even more significant.
As described above, the normal brain contains ap-
proximately 60 mg of non-heme iron distributed in
the parenchyma and an increase in this value could
represent a risk. Because of the relative accessibility
of blood, liver and bone marrow, there have been
many more direct studies of iron metabolism in the-
se organs than of that in the brain and, the great
deal is known of the role of iron in the physiology
and pathology of tissues outside the Central Ner-
vous system (CNS) and their diseases related with
an increase of iron oxides amounts (Schenck y Zim-
merman, 2004).
The striatum and hippocampus are important
structures in the brain and they are associated with
the development of Parkinson’s andAlzheimer’s di-
seases (Wu et al., 2013; Dobson, 2001). In vitro stu-
dies have demonstrated that, bare Fe3O4-NPs may
decrease neuron viability, trigger oxidative stress,
and activate JNK- and p53-mediated pathways to
regulate the cell cycle and apoptosis. These results
suggest that environmental exposure to Fe3O4-NPs
may play a role in development of neurodegenera-
tive diseases. Over PC 12 cells Xue and co-workers
(2012) have conducted a study over four different
Nanoparticles (SiO2-NPs, TiO2-NPs, Hydroxyapap-
tite (HPA)-NPs and Fe3O4-NPs) and they have sho-
wed variably enhanced secretion of cytokines bymi-
croglia. Several of these soluble factors produced by
NP-treated microglia affected dopamine synthesis
through the suppression of Th expression and also
caused cytotoxicity to PC12 cells. This study provi-
des important evidence into the potentially adverse
effects on neurons via microglia exposed in vitro
Neuro-cytotoxicity and coating relationships
must be assessed, with toxic effect of IONPs need to
be considered. According to Deng and co-workers
(2014) after exposure to different concentration of
Silicon Fiber (SF)- Fe3O4-NPs, the reactive oxygen
species generation in PC12 cells were reduced com-
paredwith uncoated Fe3O4-NPs. 1 to 5 days of treat-
ment with SF- Fe3O4-NPs did not destroy cell mem-
brane and cyto-skeleton, and could improve the
neurons extension in a dose-dependent manner at
lower concentration (6.25 − 50 g/mL), because SF
peptide coating could delay the release of iron ions
and the increase of surface crystal defects of Fe3O4-
NPs. Intact mitochondria in a neurons indicate the
extension activity of neurons of cells treated with
SF-NPs.
5. Conclusions
At present, there is a considerable lack of infor-
mation about general toxicity and neurotoxicity of
Fe3O4-NPs, this lack makes imperative to assess its
risk. The potential multifunctional application and
new developments in biomedical application based
on Fe3O4-NPs increase the risk of exposure. Emer-
ging industries bring multiple work-place risk of ex-
posure and, disposition after use of Fe3O4-NPs also
brings an environmental risk of human exposure or
ecosystems release. At the moment, there is no in-
formation about limits of exposure or referential va-
lues that can use as reference in any exposure sce-
nery. In this regard and considering the transloca-
tion of Fe3O4-NPs, potential applications, approved
used and incidental exposure, their toxicity must be
estimated.
Iron oxide nanoparticles are widely used in the
biomedical fields such as: MRI, drug and gene ca-
rriers, hyperthermia treatment agent, and magne-
tic separation. It is of significant meaning to assess
the potential risks of IONPs considering their exten-
sive applications. IONPs have become increasingly
evident a factor, that might contribute to the deve-
lopment of neurodegenerative diseases, such as Par-
kinson’s and Alzheimer’s disease. Regardless of the
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route used to deliver drugs into the brain, the dif-
fusion of the drug delivery devices into the brain
parenchyma must be controllable and must avoid
activation of microglial cells, since the brain posses-
ses its own macrophage population, the microglia,
which is involved in the development of neurode-
generative disorders.
Due to IONPs diameter variability, coatingmate-
rial used and surface charge, all result of toxic expe-
riments have presented a greater variability reflexed
over literature, for this reason, it is necessary assess
one by one, every single IONPs bare or coated used
or in development process.
At the present, IONPs are involved in biomedi-
cal and biotechnological applications, this is due to
their good tolerance evidenced by in vivo studies (Pi-
sanic et al., 2007; Wang et al., 2011). Furthermore,
the surface engineered IONPs (e.g. with targeting
ligand/ molecules attached to their surfaces) used
together with the aid of an external magnetic field
is recognized as a modern technology to introduce
particles to the desired site, where the drug is relea-
sed locally, and it represents a great advantage to
IONPs per se. Engineered IONPs, such a system, ha-
ve the potential to minimize the side effects and to
release the required dosage of the drugs at the target
site/tissue (Kim et al., 2012). These affirmations and
the fact that some IONPs (with different coating ma-
terials) are approved by FDA (Carenza et al., 2014;
Araki et al., 2013; Kong et al., 2012; Gupta et al., 2007),
implies IONPs are safe for human uses, biomedi-
cal applications and nanobiotechnological develop-
ments (Kim et al., 2012), on the contrary consumer
safety are still unknown, and it would be needed to
test the “real risk” exposure, since, once the enginee-
red IONPs are inside the cells, the coating is likely
digested leaving bare particles exposed to cellular
components and organelles thereby potentially in-
fluencing the overall integrity of the cells.
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